The antidepressant-like effect of inosine in the FST is associated with both adenosine A1 and A2A receptors

Purinergic Signalling

Volumn 9, Issue 3, 2013, Pages 481-486

  Kaster, Manuella P ^b   Budni, Josiane ^a   Gazal, Marta ^b   Cunha, Mauricio P ^a   Santos, Adair R S ^a   Rodrigues, Ana Lúcia S ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b CATHOLIC UNIVERSITY OF PELOTAS   (Brazil)

Author keywords

Adenosine receptors; Antidepressant; Forced swimming test; Inosine

Indexed keywords

6 N [2 (3, 5 DIMETHOXYPHENYL) 2 (2 METHYLPHENYL) ETHYL] ADENOSINE; 8 CYCLOPENTYL 1, 3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE DEAMINASE INHIBITOR; CYCLOHEXYLADENOSINE; ERYTHRO 9 (2 HYDROXY 3NONYL) ADENINE; INOSINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DEPRESSION; FORCED SWIMMING TEST; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST; TAIL SUSPENSION TEST;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSION; DISEASE MODELS, ANIMAL; INOSINE; MALE; MICE; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A2A; STRESS, PSYCHOLOGICAL;

EID: 84883447161     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-013-9361-8     Document Type: Article

References (40)

1. Andlin-Sobocki P, Jonsson B, Wittchen HU, Olesen J (2005) Cost of disorders of the brain in Europe. Eur J Neurol 12(Suppl 1): 1-27.
2. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psych 62(6): 593-602.
3. Gomes CV, Kaster MP, Tome AR, Agostinho PM, Cunha RA (2012) Adenosine receptors and brain diseases: neuroprotection and neurodegeneration. Biochim Biophys Acta 1808(5): 1380-1399.
4. 2A receptors in psychiatric disorders. Curr Pharmacol Des 14(15): 1512-1524.
5. Scaccianoce S, Navarra D, Sciullo AD, Angelucci L, Endröczi E (1989) Adenosine and pituitary-adrenocortical axis activity in the rat. Neuroendocrinology 50: 464-468.
6. Okada M, Nutt DJ, Murakami T, Zhu G, Kamata A, Kawata Y, Kaneko S (2001) Adenosine receptor subtypes modulate two major functional pathways for hippocampal serotonin release. J Neurosci 21: 628-640.
7. Barankiewicz J, Cohen A (1985) Purine nucleotide metabolism in resident and activated rat macrophages in vitro. Eur J Immunol 15(6): 627-631.
8. Fredholm BB, Sollevi A (1981) The release of adenosine and inosine from canine subcutaneous adipose tissue by nerve stimulation and noradrenaline. J Physiol 313: 351-367.
9. Benowitz LI, Goldberg DE, Irwin N (2002) Inosine stimulates axon growth in vitro and in the adult CNS. Prog Brain Res 137: 389-399.
10. Haskó G, Sitkovsky MV, Szabo C (2004) Immunomodulatory and neuroprotective effects of inosine. Trends Pharmacological Sci 25(3): 152-157.
11. Kovacs Z, Dobolyi A, Juhasz G, Kekesi KA (2009) Nucleoside map of the human central nervous system. Neurochem Res 35(3): 452-464.
12. Marchand WR, Lee JN, Suchy Y, Johnson S, Thatcher J, Gale P (2012) Aberrant functional connectivity of cortico-basal ganglia circuits in major depression. Neurosci Lett 514(1): 86-90.
13. Liu F, You SW, Yao LP, Liu HL, Jiao XY, Shi M, Zhao QB, Ju G (2006) Secondary degeneration reduced by inosine after spinal cord injury in rats. Spinal Cord 44(7): 421-426.
14. Hasko G, Kuhel DG, Nemeth ZH, Mabley JG, Stachlewitz RF, Virag L, Lohinai Z, Southan GJ, Salzman AL, Szabo C (2000) Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock. J Immunol 164(2): 1013-1019.
15. Liaudet L, Mabley JG, Soriano FG, Pacher P, Marton A, Hasko G, Szabo C (2001) Inosine reduces systemic inflammation and improves survival in septic shock induced by cecal ligation and puncture. Am J Respir Crit Medicine 164(7): 1213-1220.
16. Nascimento FP, Figueredo SM, Marcon R, Martins DF, Macedo SJ Jr, Lima DA, Almeida RC, Ostroski RM, Rodrigues AL, Santos AR (2010) Inosine reduces pain-related behavior in mice: involvement of adenosine A1 and A2A receptor subtypes and protein kinase C pathways. J Pharmacol Exp Therapeut 334(2): 590-598.
17. 2+ channels in the antinociceptive effect of inosine. Purinergic Signal 9(1): 51-58.
18. Irwin N, Li YM, O'Toole JE, Benowitz LI (2006) Mst3b, a purine-sensitive Ste20-like protein kinase, regulates axon outgrowth. Proc Natl Acad Sci U S A 103(48): 18320-18325.
19. Chen P, Goldberg DE, Kolb B, Lanser M, Benowitz LI (2002) Inosine induces axonal rewiring and improves behavioral outcome after stroke. Proc Natl Acad Sci USA 99(13): 9031-9036.
20. Giannecchini M, Matteucci M, Pesi R, Sgarrella F, Tozzi MG, Camici M (2005) Uptake and utilization of nucleosides for energy repletion. Int J Biochem Cell Biol 37(4): 797-808.
21. 2A receptors. Neurosci Lett 355(1-2): 21-24.
22. Martins DF, Mazzardo-Martins L, Soldi F, Stramosk J, Piovezan AP, Santos AR (2013) High-intensity swimming exercise reduces neuropathic pain in an animal model of complex regional pain syndrome type I: evidence for a role of the adenosinergic system. Neuroscience 3(234): 69-76.
23. Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229(2): 327-336.
24. Kaster MP, Budni J, Binfare RW, Santos AR, Rodrigues AL (2007) The inhibition of different types of potassium channels underlies the antidepressant-like effect of adenosine in the mouse forced swimming test. Prog Neuropsychopharmacol Biol Psychiatry 31(3): 690-696.
25. Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85(3): 367-370.
26. Posser T, Kaster MP, Barauna SC, Rocha JB, Rodrigues AL, Leal RB (2009) Antidepressant-like effect of the organoselenium compound ebselen in mice: evidence for the involvement of the monoaminergic system. Eur J Pharmacol 602(1): 85-91.
27. Bai F, Li X, Clay M, Lindstrom T, Skolnick P (2001) Intra- and interstrain differences in models of "behavioral despair". Pharmacol Biochem Behav 70: 187-192.
28. Bettio LE, Cunha MP, Budni J, Pazini FL, Oliveira A, Colla AR, Rodrigues AL (2012) Guanosine produces an antidepressant-like effect through the modulation of NMDA receptors, nitric oxide-cGMP and PI3K/mTOR pathways. Behav Brain Res 234(2): 137-148.
29. Eckeli AL, Dach F, Rodrigues AL (2000) Acute treatments with GMP produce antidepressant-like effects in mice. Neuroreport 11(9): 1839-1843.
30. Deng YH, Kuang SJ, Hei MY, Tian L (2006) Effects of inosine on neuronal apoptosis and the expression of cytochrome C mRNA following hypoxic-ischemic brain damage in neonatal rats. Chinese J Contemp Ped 8(4): 266-271.
31. Wu MM, You SW, Hou B, Jiao XY, Li YY, Ju G (2003) Effects of inosine on axonal regeneration of axotomized retinal ganglion cells in adult rats. Neurosci Lett 341(1): 84-86.
32. Starling RD, Trappe TA, Short KR, Sheffield-Moore M, Jozsi AC, Fink WJ, Costill DL (1996) Effect of inosine supplementation on aerobic and anaerobic cycling performance. Med Science SportsExerc 28(9): 1193-1198.
33. McNaughton L, Dalton B, Tarr J (1999) Inosine supplementation has no effect on aerobic or anaerobic cycling performance. Int J Sport Nut 9(4): 333-344.
34. Lobato KR, Binfare RW, Budni J, Rosa AO, Santos AR, Rodrigues AL (2008) Involvement of the adenosine A1 and A2A receptors in the antidepressant-like effect of zinc in the forced swimming test. Prog Neuro-Psychopharmacol Biol Psych 32(4): 994-999.
35. Gao Z, Li BS, Day YJ, Linden J (2001) A3 adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2H3 mast cells from apoptosis. Mol Pharmacol 59(1): 76-82.
36. Szabo C, Dawson VL (1998) Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci 19(7): 287-298.
37. Ames BN, Cathcart R, Schwiers E, Hochstein P (1981) Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A 78(11): 6858-6862.
38. Becker BF, Reinholz N, Ozcelik T, Leipert B, Gerlach E (1989) Uric acid as radical scavenger and antioxidant in the heart. Pflugers Arch 415(2): 127-135.
39. Wen S, Cheng M, Wang H, Yue J, Wang H, Li G, Zheng L, Zhong Z, Peng F (2012) Serum uric acid levels and the clinical characteristics of depression. Clinical Biochem 45(1-2): 49-53.
40. Pastor-Anglada M, Casado FJ, Valdes R, Mata J, Garcia-Manteiga J, Molina M (2001) Complex regulation of nucleoside transporter expression in epithelial and immune system cells. Mol Mem Biol 18(1): 81-85.